Synopsis of recent research by authors named "Linda Laaouad"
- Linda Laaouad's research primarily focuses on the safety and efficacy of immune checkpoint inhibitors (ICIs) in patients with preexisting autoimmune diseases (PAD), highlighting the need for more comprehensive data in this area.
- In her notable publication, she conducted a retrospective study examining patients with PAD who were referred for rheumatologic evaluation prior to or during anti-PD-1 cancer immunotherapy, showcasing findings from 10 academic sites across Canada.
- The study, published in "Cancer Immunology Immunotherapy," presents critical insights into the incidence of immune-related adverse events in PAD patients undergoing ICIs, a topic that remains underexplored in current oncology literature.
